CMS Part D Protected Class Restrictions Drawing Bipartisan Concerns In Congress
Executive Summary
Congressional objections to proposal join opposition by patient and physician groups.
You may also be interested in...
Part D Brand Discounts May Be More Useful In Catastrophic Phase, House Panel Told
Medicare Payment Advisory Commission executive director Mathews suggests at April 30 hearing that manufacturers should bear more “liability” for catastrophic coverage in Medicare Part D.
Running The Gauntlet: Takeaways From The First Round Of HHS Hearings In 2019
Release of the White House budget proposal kicked off the first round of hearings on HHS with a new Democratic majority in the House and a new HHS budget czar in the Senate. HHS Secretary Azar did his best to set a constructive tone for advancing drug pricing policies – and maintaining his own position – in the year to come.
Part D Protected Class Management Tools To Save Medicare $1.85bn
CMS proposed rule would not eliminate any protected classes but would allow plans to impose additional restrictions on drugs in those classes. Proposal also codifies step therapy for Part B drugs.